Wu GS - Search Results

1

Developing TRAIL/TRAIL death receptor-based cancer therapies.

Yuan X, Gajan A, Chu Q, Xiong H, Wu K, Wu GS. Yuan X, et al. Among authors: wu gs, wu k. Cancer Metastasis Rev. 2018 Dec;37(4):733-748. doi: 10.1007/s10555-018-9728-y. Cancer Metastasis Rev. 2018. PMID: 29541897 Free PMC article. Review.

2

p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.

Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace AJ Jr, el-Deiry WS. Sheikh MS, et al. Among authors: wu gs. Cancer Res. 1998 Apr 15;58(8):1593-8. Cancer Res. 1998. PMID: 9563466

3

Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.

Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS. Wu GS, et al. Cancer Res. 1999 Jun 15;59(12):2770-5. Cancer Res. 1999. PMID: 10383128

4

Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy.

Xu J, Zhou JY, Wu GS. Xu J, et al. Among authors: wu gs. Cancer Res. 2006 Oct 15;66(20):10092-9. doi: 10.1158/0008-5472.CAN-06-1633. Cancer Res. 2006. PMID: 17047073

5

Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin.

Xu J, Zhou JY, Tainsky MA, Wu GS. Xu J, et al. Among authors: wu gs. Cancer Res. 2007 Feb 1;67(3):1203-11. doi: 10.1158/0008-5472.CAN-06-2310. Cancer Res. 2007. PMID: 17283156

6

Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer.

Wu GS. Wu GS. Cancer Metastasis Rev. 2007 Dec;26(3-4):579-85. doi: 10.1007/s10555-007-9079-6. Cancer Metastasis Rev. 2007. PMID: 17717636 Review.

7

ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.

Wang J, Zhou JY, Wu GS. Wang J, et al. Among authors: wu gs. Cancer Res. 2007 Dec 15;67(24):11933-41. doi: 10.1158/0008-5472.CAN-07-5185. Cancer Res. 2007. PMID: 18089824

8

Sp1-mediated TRAIL induction in chemosensitization.

Xu J, Zhou JY, Wei WZ, Philipsen S, Wu GS. Xu J, et al. Among authors: wu gs. Cancer Res. 2008 Aug 15;68(16):6718-26. doi: 10.1158/0008-5472.CAN-08-0657. Cancer Res. 2008. PMID: 18701496 Free PMC article.

9

TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death.

Kuribayashi K, Krigsfeld G, Wang W, Xu J, Mayes PA, Dicker DT, Wu GS, El-Deiry WS. Kuribayashi K, et al. Among authors: wu gs. Cancer Biol Ther. 2008 Dec;7(12):2034-8. doi: 10.4161/cbt.7.12.7460. Cancer Biol Ther. 2008. PMID: 19106633

10

TRAIL as a target in anti-cancer therapy.

Wu GS. Wu GS. Cancer Lett. 2009 Nov 18;285(1):1-5. doi: 10.1016/j.canlet.2009.02.029. Epub 2009 Mar 18. Cancer Lett. 2009. PMID: 19299078 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page